197 related articles for article (PubMed ID: 25974708)
1. Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.
Omar AM; Mahran MA; Ghatge MS; Chowdhury N; Bamane FH; El-Araby ME; Abdulmalik O; Safo MK
Org Biomol Chem; 2015 Jun; 13(22):6353-70. PubMed ID: 25974708
[TBL] [Abstract][Full Text] [Related]
2. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
Omar AM; Mahran MA; Ghatge MS; Bamane FH; Ahmed MH; El-Araby ME; Abdulmalik O; Safo MK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529207
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
[TBL] [Abstract][Full Text] [Related]
4. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK
Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
[TBL] [Abstract][Full Text] [Related]
6. Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.
Deshpande TM; Pagare PP; Ghatge MS; Chen Q; Musayev FN; Venitz J; Zhang Y; Abdulmalik O; Safo MK
Acta Crystallogr D Struct Biol; 2018 Oct; 74(Pt 10):956-964. PubMed ID: 30289405
[TBL] [Abstract][Full Text] [Related]
7. An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling.
Omar AM; Abdulmalik O; Ghatge MS; Muhammad YA; Paredes SD; El-Araby ME; Safo MK
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33147875
[TBL] [Abstract][Full Text] [Related]
8. Targeted modification of furan-2-carboxaldehydes into Michael acceptor analogs yielded long-acting hemoglobin modulators with dual antisickling activities.
Omar AM; Abdulmalik O; El-Say KM; Ghatge MS; Cyril-Olutayo M; Paredes S; Al-Awadh M; El-Araby ME; Safo MK
Chem Biol Drug Des; 2024 Jan; 103(1):e14371. PubMed ID: 37798397
[TBL] [Abstract][Full Text] [Related]
9. Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents.
Omar AM; David T; Pagare PP; Ghatge MS; Chen Q; Mehta A; Zhang Y; Abdulmalik O; Naghi AH; El-Araby ME; Safo MK
Medchemcomm; 2019 Nov; 10(11):1900-1906. PubMed ID: 32206236
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.
Abdulmalik O; Ghatge MS; Musayev FN; Parikh A; Chen Q; Yang J; Nnamani I; Danso-Danquah R; Eseonu DN; Asakura T; Abraham DJ; Venitz J; Safo MK
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):920-8. PubMed ID: 22101818
[TBL] [Abstract][Full Text] [Related]
11. Identification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its Polymerization.
Purvis SH; Keefer JR; Fortenberry YM; Barron-Casella EA; Casella JF
Nucleic Acid Ther; 2017 Dec; 27(6):354-364. PubMed ID: 29039727
[TBL] [Abstract][Full Text] [Related]
12. Pyridyl derivatives of benzaldehyde as potential antisickling agents.
Nnamani IN; Joshi GS; Danso-Danquah R; Abdulmalik O; Asakura T; Abraham DJ; Safo MK
Chem Biodivers; 2008 Sep; 5(9):1762-9. PubMed ID: 18816529
[TBL] [Abstract][Full Text] [Related]
13. Identification of 2-imidazolines as anti-sickling agents.
Chang H; Ewert SM; Nagel RL
Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
[TBL] [Abstract][Full Text] [Related]
14. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
15. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.
Kassa T; Strader MB; Nakagawa A; Zapol WM; Alayash AI
Metallomics; 2017 Sep; 9(9):1260-1270. PubMed ID: 28770911
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.
Mahran MA
Boll Chim Farm; 2000; 139(2):73-80. PubMed ID: 10920532
[TBL] [Abstract][Full Text] [Related]
17. VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.
Abdulmalik O; Pagare PP; Huang B; Xu GG; Ghatge MS; Xu X; Chen Q; Anabaraonye N; Musayev FN; Omar AM; Venitz J; Zhang Y; Safo MK
Sci Rep; 2020 Nov; 10(1):20277. PubMed ID: 33219275
[TBL] [Abstract][Full Text] [Related]
18. Targeting HbS Polymerization.
Ferrone FA
Semin Hematol; 2018 Apr; 55(2):53-59. PubMed ID: 30616807
[TBL] [Abstract][Full Text] [Related]
19. Specific chemical modifications in the beta-cleft site of hemoglobin. Potential anti-sickling agents with hybrid functionalities.
Klotz IM; Haney DN; Wood LE
J Biol Chem; 1985 Dec; 260(30):16215-23. PubMed ID: 4066708
[TBL] [Abstract][Full Text] [Related]
20. A mass spectrometry screening method for antiaggregatory activity of proteins covalently modified by combinatorial library members: application to sickle hemoglobin.
Park S; Wanna L; Johnson ME; Venton DL
J Comb Chem; 2000; 2(4):314-7. PubMed ID: 10891097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]